MAM
GMAB icon

Madison Asset Management’s Genmab GMAB Stock Holding History

Madison Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Sell
70,781
-189
-0.3% -$5.02K 0.02% 268
2026
Q1 		$1.9M Buy
70,970
+4,479
+7% +$134K 0.02% 259
2025
Q4 		$2.05M Buy
66,491
+4,999
+8% +$156K 0.02% 245
2025
Q3 		$1.89M Sell
61,492
-1,438
-2% -$35K 0.02% 244
2025
Q2 		$1.3M Buy
62,930
+567
+0.9% +$11.6K 0.01% 273
2025
Q1 		$1.22M Buy
62,363
+15,459
+33% +$324K 0.01% 269
2024
Q4 		$979K Sell
46,904
-20,785
-31% -$457K 0.01% 285
2024
Q3 		$1.65M Buy
67,689
+9,114
+16% +$244K 0.02% 267
2024
Q2 		$1.47M Sell
58,575
-3,099
-5% -$87.9K 0.02% 272
2024
Q1 		$1.84M Buy
61,674
+12,732
+26% +$374K 0.02% 265
2023
Q4 		$1.56M Sell
48,942
-26,493
-35% -$832K 0.02% 272
2023
Q3 		$2.66M Buy
75,435
+8,738
+13% +$333K 0.04% 232
2023
Q2 		$2.54M Sell
66,697
-607
-0.9% -$24.2K 0.04% 238
2023
Q1 		$2.54M Buy
67,304
+8,495
+14% +$327K 0.04% 232
2022
Q4 		$2.49M Sell
58,809
-12,630
-18% -$520K 0.04% 227
2022
Q3 		$2.29M Buy
71,439
+14,777
+26% +$519K 0.04% 233
2022
Q2 		$1.84M Sell
56,662
-4,386
-7% -$142K 0.03% 270
2022
Q1 		$2.21M Buy
61,048
+11,066
+22% +$380K 0.03% 236
2021
Q4 		$1.98M Sell
49,982
-16,014
-24% -$668K 0.03% 252
2021
Q3 		$2.88M Buy
65,996
+10,953
+20% +$492K 0.04% 241
2021
Q2 		$2.25M Sell
55,043
-9,939
-15% -$384K 0.03% 254
2021
Q1 		$2.13M Sell
64,982
-4,821
-7% -$181K 0.03% 251
2020
Q4 		$2.84M Buy
+69,803
New +$2.61M 0.04% 237

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Madison Asset Management's GMAB Position: Q2 2026 in Review

Madison Asset Management reduced its Genmab (GMAB) stake by 0.27% in Q2 2026, selling an estimated $5.02K and leaving 70,781 shares worth $1.94M. The position accounts for 0.02% of the portfolio, ranked #268.

Madison Asset Management first reported a position in GMAB in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.88M in Q3 2021. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Madison Asset Management held 70,781 shares of Genmab worth $1.94M as of Q2 2026.
  • Madison Asset Management sold 189 Genmab shares in Q2 2026, an estimated $5.02K.
  • Genmab made up 0.02% of Madison Asset Management's portfolio in Q2 2026, its #268 holding.
  • Madison Asset Management first reported a position in Genmab in Q4 2020 and has held it in 23 quarters since.
  • Madison Asset Management's Genmab position peaked at $2.88M in Q3 2021.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Madison Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.